U.S. Markets open in 9 hrs 27 mins

CytRx Corporation (CYTR)


NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.51-0.18 (-25.69%)
At close: 4:00PM EDT
People also watch
GALECRISCYCCCVMCTIC
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close0.68
Open0.55
Bid0.51 x 1200
Ask0.53 x 3800
Day's Range0.50 - 0.56
52 Week Range0.36 - 3.44
Volume25,491,847
Avg. Volume3,568,692
Market Cap60.41M
Beta1.69
PE Ratio (TTM)-0.81
EPS (TTM)-0.63
Earnings DateMay 9, 2017 - May 15, 2017
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est4.00
Trade prices are not sourced from all markets
  • PR Newswire3 days ago

    CytRx Corporation Announces Pricing of $15 Million Public Offering of Common Stock

    LOS ANGELES, April 28, 2017 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that it has priced a public offering of approximately 30 million shares of its common stock at a purchase price of $0.50 per share, for gross proceeds of approximately $15 million. H.C. Wainwright & Co. is acting as exclusive placement agent for the offering. After deducting the placement agent's fees and other estimated offering expenses payable by CytRx, the net proceeds to CytRx are anticipated to be approximately $13.8 million. CytRx intends to use the net proceeds from the offering for working capital and general corporate purposes, including clinical and regulatory activities, new drug discovery activities, and possible future strategic transactions.

  • PR Newswire3 days ago

    CytRx Corporation Announces Proposed Public Offering of Common Stock

    LOS ANGELES, April 27, 2017 /PRNewswire/ -- CytRx Corporation (CYTR), a biopharmaceutical research and development company specializing in oncology today announced a proposed public offering of its common stock. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be consummated, or as to the actual size or terms of the offering. H.C. Wainwright & Co. is acting as exclusive placement agent for the offering.

  • Investopedia3 days ago

    Penny Stocks to Watch for May 2017

    These ten penny stocks trading on U.S. public exchanges could gain substantial ground in April 2017 and the coming months.